Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, August 11, 2014

Experimental pathologist Jorge Reis-Filho explains how tumor DNA obtained from the blood could lead to noninvasive — yet highly sensitive — ways of detecting and monitoring cancer in the body.

Pictured: Serge Lyashchenko
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, June 27, 2014

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

Pictured: Christine Iacobuzio-Donahue, Eileen O’Reilly, Steven Leach, and Peter Allen
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, June 26, 2014

Our new David M. Rubenstein Center for Pancreatic Cancer Research is an ambitious initiative to solve a difficult and complex disease.

Pictured: Vivian Strong
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, June 24, 2014

Memorial Sloan Kettering diagnoses and treats more people with stomach cancer than any other cancer center in the nation.

Pictured: Michael Berger
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, June 12, 2014

A powerful diagnostic test, MSK-IMPACT™ gives our doctors an unparalleled amount of information about individual people’s cancers to guide their treatment.

Pictured: Dean Bajorin
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Wednesday, May 7, 2014

Each year, hundreds of people choose Memorial Sloan Kettering for diagnosis and treatment of bladder cancer.

Pictured: Michelle Bradbury
Q&A
By Jim Stallard, MA, Writer/Editor  |  Thursday, April 24, 2014

A new optical-imaging approach could enable surgeons to more precisely visualize cancerous tissue during an operation.

Cancer Guide
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 17, 2014

Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.

Pictured: Kenneth Offit, Alexandra Heerdt, Emily Glogowski & Max Gomez
Video
By Helen Garey, MPH, Freelance Writer  |  Wednesday, March 26, 2014

Cancer genetics experts say the discovery of the BRCA gene mutations has transformed the way doctors prevent and treat hereditary cancers. Read the post and watch the video.

Pictured: George Plitas
Perspective
By George Plitas, MD  |  Friday, March 14, 2014

The correct identification and naming of a tumor’s type is increasingly important in the era of personalized medicine, and tumors that exhibit features of more than one type can complicate that process.

Pictured: Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, March 10, 2014

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

Vincent Laudone
Perspective
By Vincent Laudone, MD, Co-Director for Robotic Surgery  |  Tuesday, March 4, 2014

Our conversation about active surveillance of prostate cancer continues. Let’s take a closer look at our protocols for selecting and monitoring patients.

Pictured: William Jarnagin
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, February 25, 2014

Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.

In the News
By Media Staff  |  Wednesday, February 12, 2014

Breast cancer experts criticize study suggesting mammograms don’t save lives.

Center News

Stay Informed

Get the latest information about cancer care and research every month.